Nitrites, Exercise, and Peripheral Arterial Disease
NCT01684930 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2017-08-29
Summary
The hypothesis of this proposal is that in subjects with PAD, regular consumption of a high nitrate supplement which raises plasma nitrite, in conjunction with 12 weeks of supervised exercise training at the limb ischemic threshold (SET) will produce a greater clinical benefit (increases in COT and PWT) than placebo plus supervised exercise at the limb ischemic threshold (PET).
Conditions
- Peripheral Arterial Disease
Interventions
- DRUG
-
Beetroot Juice (Beet-It Stamina Shot) & Supervised Exercise Training
The beverage is high in inorganic nitrate and bottled and supplied by James White Drinks. This supplement will be used in conjunction with supervised exercise training.
- OTHER
-
Placebo Comparator Beverage (Beet-It Stamina Shot) & Exercise Training
The beverage is identical in look and taste to Beet-It Stamina Shot but with active ingredient removed. It is also bottled and supplied by James White Drinks. This placebo supplement will be used in conjunction with supervised exercise training.
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH - lead OTHER
Principal Investigators
-
Jason Allen, PhD · Duke University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-06-30
- Primary Completion
- 2014-11-30
- Completion
- 2014-11-30
Countries
- United States
Study Locations
More Related Trials
-
Carnosine for Peripheral Arterial Disease Patients
NCT05371145 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Effect of Neo40 on PAD
NCT02934438 ·Status: UNKNOWN ·Phase: NA
-
L-Arginine in the Treatment of Peripheral Arterial Disease
NCT00284076 ·Status: COMPLETED ·Phase: NA
-
Carnosine for Peripheral Arterial Disease
NCT04870229 ·Status: COMPLETED ·Phase: PHASE2
-
RESveratrol To Improve Outcomes in oldeR pEople With PAD (the RESTORE Trial)
NCT02246660 ·Status: COMPLETED ·Phase: NA
-
NAD Supplementation and Vascular Health in PAD
NCT06534944 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication)
NCT00399919 ·Status: COMPLETED ·Phase: PHASE3
-
Impacts of Mitochondrial-targeted Antioxidant on Peripheral Artery Disease Patients
NCT03506633 ·Status: COMPLETED ·Phase: NA
-
Nicotinamide Riboside With and Without Resveratrol to Improve Functioning in Peripheral Artery Disease
NCT03743636 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of MST-188 in Acute Lower Limb Ischemia
NCT02093468 ·Status: TERMINATED ·Phase: PHASE2
-
Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease
NCT06319339 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Influence of Rivaroxaban for Intermittent Claudication and Exercise Tolerance in Patients With Symptomatic PAD
NCT04305028 ·Status: UNKNOWN
-
Carnosine for Peripheral Vascular Disease
NCT03844113 ·Status: UNKNOWN ·Phase: PHASE2
-
Hepatocyte Growth Factor to Improve Functioning in PAD
NCT03363165 ·Status: COMPLETED ·Phase: PHASE2
-
The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease
NCT05009862 ·Status: COMPLETED ·Phase: PHASE4
-
Cilostazol After Lower Extremity Arterial Revascularization Trial
NCT02374957 ·Status: TERMINATED ·Phase: PHASE4
-
The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication
NCT04800692 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Treatment of PAD by Platelet Lysate for Therapeutic Angiogenesis
NCT02941419 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of NCX4016 on Walking Distance in Patients With Peripheral Arterial Occlusive Disease (PAOD)
NCT01256775 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Carnosine In Patients With Peripheral Arterial Disease Patients
NCT06480760 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Pilot Study of Organic Nitrates on Endothelial Function in CAD Patients
NCT01030367 ·Status: UNKNOWN ·Phase: NA
-
Implementation of Vascular Care Team to Improve Medical Management of PAD Patients
NCT04400409 ·Status: COMPLETED ·Phase: NA
-
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
NCT06409949 ·Status: RECRUITING ·Phase: NA
-
Effects of Plant-Based Diet on Peripheral Arterial Disease
NCT03798938 ·Status: UNKNOWN
-
Sonodynamic Therapy in the Treatment of Perivascular Adipose Tissue on Patients With PAD and Claudication
NCT03967730 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2